Company profile
BioSputnik company profile
BioSputnik develops biotechnology and pharmaceutical solutions focused on RNA-based therapeutics and platform technologies for targeted drug delivery. The company explores lipid nanoparticle systems tailored for cell-specific delivery of therapeutic RNA, aiming to support early-stage therapy development. BioSputnik conducts research and development activities that span discovery, preclinical strategy, and translational planning in the life sciences domain. The organization also provides scientific and regulatory consulting, helping life science teams interpret experimental data, design development pathways, and navigate regulatory expectations for novel therapies. Engagements typically support biotechnology and pharmaceutical clients that require combined R&D insight and regulatory guidance for complex therapeutic platforms.
Business identity
- Website
- https://biosputnik.org
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 1-10 employees
- Revenue range
- $0+
- Founded
- 2019-01-01, Year
Headquarters
- Headquarters
- Newyork, Argyll and Bute, United Kingdom
- Postal code
- 10002
- Country code
- GB
- Continent
- Europe